
Wandercraft wins FDA clearance for self-balancing exoskeleton
Wandercraft, a Paris-based robotics company, announced that the FDA has granted clearance for Eve, its personal self-balancing exoskeleton designed to support upright mobility.

Wandercraft, a Paris-based robotics company, announced that the FDA has granted clearance for Eve, its personal self-balancing exoskeleton designed to support upright mobility.

BEIJING, Aug. 11, 2026 /PRNewswire/ — Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) (“Datasea” or the “Company”), a technology company focused on acoustic high-tech and AI multimodal digital solutions, today announced that Shuhai Jingwei (Shenzhen) Information Technology Co., Ltd. (“Shuhai Jingwei”), the Company’s variable interest entity in China, has completed establishment registration and device listing with the U.S. Food and Drug Administration (“FDA”) for its NeuroVibe Biofeedback System, including products NV-02 and NV-03.

BlueWind plans to initiate a limited US market launch of Revi Extend in Q4 2026.

In the 1970s, PVC bags revolutionized the storage of blood and blood products for transfusion. Disposable plastic (PVC) bags replaced reusable glass bottles, making the process more convenient and safer from contamination. Over half a century later, the same disposable plastic bags are creating a new kind of problem because of microplastics (MPs). These tiny particles, less than 5 millimeters in size, are formed by the polymer degradation of plastic materials as they break down and age.

Certification strengthens Koning’s global regulatory foundation as two new Vera Breast CT systems expand patient access in key U.S. markets

Two Northwestern experts explain how to reduce risk without sacrificing a healthy diet

BOSTON, July 16, 2026 /PRNewswire/ — HoneyNaps, an AI-based sleep medicine company, today announced that SOMNUM V3.0, its AI diagnosis software for polysomnography (PSG) analysis, has received U.S. Food and Drug Administration (FDA) clearance under clearance number K253390.

The LightningWire system is designed to support transseptal access in procedures such as atrial fibrillation ablation, left atrial appendage closure and transcatheter mitral interventions.

The disease is projected to become the fifth leading cause of death by 2040 if diagnosis and treatment rates do not improve

Learn how mechanical stretching helped lab-grown vessels sprout and redirect new capillaries, a step toward keeping engineered tissues alive.